Summary

Market Overview
The Global Cell Lysis Market was valued at USD 3.16 billion in 2024 and is projected to reach USD 4.87 billion by 2030, growing at a CAGR of 7.47% during the forecast period. This market is witnessing significant growth due to the increasing demand for cell-based research and diagnostic applications in the pharmaceutical, biotechnology, and healthcare sectors. Cell lysis—breaking open cells to access their internal components—is a foundational step in molecular biology, bioprocessing, and clinical diagnostics.
The biopharmaceutical industry's expansion and the shift toward targeted therapies and personalized medicine have intensified the need for efficient cell lysis techniques to extract proteins, DNA, and RNA. In parallel, advancements in genomics and proteomics are accelerating the adoption of advanced lysis technologies. As researchers focus on biomolecular isolation from various cell types, the demand for precise and scalable cell lysis methods continues to grow. This rising application spectrum reinforces cell lysis as a critical enabler in both therapeutic development and molecular diagnostics.
Key Market Drivers
Biopharmaceutical Advancements
The accelerating growth of the biopharmaceutical industry is a central force driving the global cell lysis market. With increasing focus on biologics and personalized medicine, pharmaceutical companies rely on advanced cell lysis methods to extract therapeutic proteins, DNA, and RNA.
Cell lysis enhances the efficiency of drug development by facilitating rapid extraction and purification of target biomolecules. This is crucial for reducing time-to-market, especially during health crises where expedited drug development is vital. Biomanufacturing processes, including antibody and protein production, depend on optimized lysis techniques to increase yield and maintain product quality.
As the complexity of therapeutic molecules increases, advanced cell lysis tools help ensure high purity and minimize contamination, which is essential for patient safety and regulatory compliance. This growing reliance on cell lysis across the drug discovery and development lifecycle ensures sustained demand for high-performance lysis products and systems.
Key Market Challenges
High Cost of Cell Lysis Equipment and Reagents
A notable challenge in the global cell lysis market is the high cost associated with equipment and reagents. High-performance instruments, such as automated and high-pressure lysis systems, require significant capital investment, which can restrict access for smaller laboratories or institutions with limited funding.
Moreover, premium-grade reagents—including enzymes, detergents, and buffers—are necessary for specific applications but can be prohibitively expensive for routine use, especially in developing countries. This limits the adoption of advanced lysis solutions and contributes to disparities in research capabilities across different regions.
Budget constraints in academic or underfunded institutions further exacerbate this issue, potentially hindering innovations in therapeutic and diagnostic research where reliable lysis techniques are essential.
Key Market Trends
Rising Demand for Biologics and Personalized Medicine
A prominent trend shaping the cell lysis market is the increasing focus on biologics and personalized therapies. The development of complex biologics—such as monoclonal antibodies, gene therapies, and vaccines—requires efficient cell lysis processes for the extraction of high-quality biomolecules.
As personalized medicine gains traction, diagnostic labs are using cell lysis to isolate DNA, RNA, and proteins for genetic profiling and biomarker analysis. This enables clinicians to tailor treatments based on individual patient data, improving efficacy and minimizing side effects.
With the biopharmaceutical industry continuously innovating in molecular and precision medicine, cell lysis systems are evolving to support specific needs in both upstream and downstream processes, ensuring compatibility with high-throughput, scalable workflows.
Key Market Players
• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Eppendorf AG
• Hoffmann-La Roche Ltd
• Labfreez Instruments Group Co. Ltd
• Merck KGaA
• Qsonica LLC
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
Report Scope:
In this report, the Global Cell Lysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Cell Lysis Market, By Type of Product:
o Instruments
o Reagents
• Cell Lysis Market, By Type of Cells:
o Mammalian Cells
o Microbial Cells
o Plant Cells
• Cell Lysis Market, By End User:
o Biotechnology or Biopharmaceutical Companies
o Research Laboratories and Academic Institutes
o Other End Users
• Cell Lysis Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
§ Turkey
§ Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cell Lysis Market.
Available Customizations:
Global Cell Lysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cell Lysis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Product (Instruments {Homogeniser, Centrifugation, Other Types of Products}, Reagents)
5.2.2. By Type of cells (Mammalian Cells, Microbial Cells, Plant Cells)
5.2.3. By End user (Biotechnology or Biopharmaceutical Companies, Research Laboratories and Academic Institutes, Other End Users)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Cell Lysis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Product
6.2.2. By Type of cells
6.2.3. By End user
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Cell Lysis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Product
6.3.1.2.2. By Type of cells
6.3.1.2.3. By End user
6.3.2. Mexico Cell Lysis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Product
6.3.2.2.2. By Type of cells
6.3.2.2.3. By End user
6.3.3. Canada Cell Lysis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Product
6.3.3.2.2. By Type of cells
6.3.3.2.3. By End user
7. Europe Cell Lysis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Product
7.2.2. By Type of cells
7.2.3. By End user
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Cell Lysis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Product
7.3.1.2.2. By Type of cells
7.3.1.2.3. By End user
7.3.2. Germany Cell Lysis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Product
7.3.2.2.2. By Type of cells
7.3.2.2.3. By End user
7.3.3. United Kingdom Cell Lysis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Product
7.3.3.2.2. By Type of cells
7.3.3.2.3. By End user
7.3.4. Italy Cell Lysis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Product
7.3.4.2.2. By Type of cells
7.3.4.2.3. By End user
7.3.5. Spain Cell Lysis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Product
7.3.5.2.2. By Type of cells
7.3.5.2.3. By End user
8. Asia-Pacific Cell Lysis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Product
8.2.2. By Type of cells
8.2.3. By End user
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Cell Lysis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Product
8.3.1.2.2. By Type of cells
8.3.1.2.3. By End user
8.3.2. India Cell Lysis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Product
8.3.2.2.2. By Type of cells
8.3.2.2.3. By End user
8.3.3. South Korea Cell Lysis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Product
8.3.3.2.2. By Type of cells
8.3.3.2.3. By End user
8.3.4. Japan Cell Lysis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Product
8.3.4.2.2. By Type of cells
8.3.4.2.3. By End user
8.3.5. Australia Cell Lysis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Product
8.3.5.2.2. By Type of cells
8.3.5.2.3. By End user
9. South America Cell Lysis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Product
9.2.2. By Type of cells
9.2.3. By End user
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Cell Lysis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Product
9.3.1.2.2. By Type of cells
9.3.1.2.3. By End user
9.3.2. Argentina Cell Lysis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Product
9.3.2.2.2. By Type of cells
9.3.2.2.3. By End user
9.3.3. Colombia Cell Lysis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Product
9.3.3.2.2. By Type of cells
9.3.3.2.3. By End user
10. Middle East and Africa Cell Lysis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Product
10.2.2. By Type of cells
10.2.3. By End user
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Cell Lysis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Product
10.3.1.2.2. By Type of cells
10.3.1.2.3. By End user
10.3.2. Saudi Arabia Cell Lysis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Product
10.3.2.2.2. By Type of cells
10.3.2.2.3. By End user
10.3.3. UAE Cell Lysis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Product
10.3.3.2.2. By Type of cells
10.3.3.2.3. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. Competitive Landscape
15.1. Becton, Dickinson and Company
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Bio-Rad Laboratories Inc.
15.3. Danaher Corporation
15.4. Eppendorf AG
15.5. Hoffmann-La Roche Ltd
15.6. Labfreez Instruments Group Co. Ltd
15.7. Merck KGaA
15.8. Qsonica LLC
15.9. Takara Bio Inc.
15.10. Thermo Fisher Scientific Inc.
16. Strategic Recommendations
17. About Us & Disclaimer